BSE filing, NSE: MUKTAARTS. Summary written from the filing by ALFA Finder's alert engine.
Mukta Arts Ltd: key numbers
- Share price
- ₹46.95
- Market cap
- ₹106.0 Cr
- Revenue (annual)
- ₹173.9 Cr
- Net profit (annual)
- ₹-11.80 Cr
- P/E (TTM)
- -13.5×Sector 28.2×
- Promoter holding
- 70.71%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mukta Arts Ltd
All →Mukta Arts Board Meeting Date
Mukta Arts will hold a board meeting on 5 November 2026 to consider unaudited half-year results. The trading window stays closed until the results are declared.
Mukta Arts Other Announcement
Mukta Arts Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ending September 2026.
Mukta Arts Annual General Meeting
Mukta Arts Limited issued a Postal Ballot Notice seeking shareholder approval for a material related party transaction with its subsidiary, Mukta A2 Cinemas Private Limited.
Mukta Arts Other Announcement
Mukta Arts Ltd submitted the Regulation 74(5) certificate for the quarter ended September 30, 2026, confirming no dematerialization requests were received.
Mukta Arts Merger & Restructuring Worth ₹10 Cr
Mukta Arts will dilute its stake in subsidiary Mukta A2 Cinemas, reclassifying it as an associate company, via a ₹10 Crore fundraise agreement.
- Value
- ₹10.00 Cr
Mukta Arts Merger & Restructuring
Mukta Arts shareholders approved the adoption of financial statements and the re-appointment of Director Parvez Farooqui at the AGM. They also authorized the divestment of a subsidiary.
Other board meeting date announcements
All →HCP Plastene Bulkpack Board Meeting Date
HCP Plastene Bulkpack scheduled a board meeting for 06 November 2026. It will consider unaudited results for the quarter and half year ending 30 September 2026.
Ultracab (India) Board Meeting Date
Ultracab (India) Ltd intimated that its Board meeting is scheduled for 04-Nov-2026 to consider unaudited standalone financial results. No results or financial figures are disclosed in this advance notice.
Texmaco Infrastructure & Holdings Board Meeting Date
Texmaco has scheduled a Board meeting on November 5, 2026, to approve Q2 and H2 FY27 financial results. Trading window stays closed for insiders pending results declaration.
Astonea Labs Board Meeting Date
Astonea Labs intimated that its Board is scheduled on 14 Nov 2026 to consider unaudited half-year results. The trading window remains closed until 48 hours post-announcement.
AstraZeneca Pharma India Board Meeting Date
AstraZeneca Pharma India scheduled its board meeting for 5 Nov 2026 to approve Q2/H1 FY27 results. The trading window remains closed until 7 Nov 2026.
Mafatlal Industries Board Meeting Date
Mafatlal Industries updated that its 4 November 2026 board meeting will consider an interim dividend for FY27. Record date, if approved, is 13 November 2026.